Evidence map›Paper›PMID 38260751›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Draft genome analysis for

Hossam S El-Beltagi, Asmaa A Halema, Zainab M Almutairi, Hayfa Habes Almutairi, Nagwa I Elarabi, Abdelhadi A Abdelhadi, Ahmed R Henawy, Heba A R Abdelhaleem

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Innovative optimization for enhancing PbFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Hossam S El-Beltagi *Agricultural Biotechnology Department, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa, Saudi Arabi.
Asmaa A Halema *Genetics Department, Faculty of Agriculture, Cairo University, Giza, Egypt.
Zainab M Almutairi *Biology Department, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Hayfa Habes AlmutairiDepartment of Chemistry, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia.
Nagwa I ElarabiGenetics Department, Faculty of Agriculture, Cairo University, Giza, Egypt.
Abdelhadi A AbdelhadiGenetics Department, Faculty of Agriculture, Cairo University, Giza, Egypt.
Ahmed R HenawyMicrobiology Department, Faculty of Agriculture, Cairo University, Giza, Egypt.
Heba A R AbdelhaleemCollege of Biotechnology, Misr University for Science and Technology (MUST), 6th October City, Egypt.
Cairo University · EGKing Faisal University · SAMisr University for Science and Technology · EGPrince Sattam Bin Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lead pollution of the environment poses a major global threat to the ecosystem. Bacterial bioremediation offers a promising alternative to traditional methods for removing these pollutants, that are often hindered by various limitations. Our research focused on isolating lead-resistant bacteria from industrial wastewater generated by heavily lead-containing industries. Eight lead-resistant strains were successfully isolated, and subsequently identified through molecular analysis. Among these,

Indexed as

bioremediationgenome analysisheavy metal resistant bacterialeadqPCRTEM

Identifiers

PMID38260751
PMCPMC10800491
OpenAlexW4390665320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.